Hypermarcas (OTCMKTS:HYPMY) Shares Shorted: Short Interest Down 62.4% in September

Hypermarcas (OTCMKTS:HYPMY) saw a significant decrease in short interest in September. As of September 15th, there was short interest totaling 2,343 shares, a decrease of 62.4% from the August 31st total of 6,225 shares. Based on an average daily volume of 12,182 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.0% of the shares of the company are sold short.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group upgraded shares of Hypermarcas to a “strong-buy” rating in a research note on Monday, July 20th. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy”.

Hypermarcas Price Performance

Shares of OTCMKTS HYPMY traded up $0.01 during mid-day trading on Friday, reaching $4.65. 2,608 shares of the company traded hands, compared to its average volume of 8,066. Hypermarcas has a fifty-two week low of $3.71 and a fifty-two week high of $5.50. The firm has a market cap of $3.27 billion, a PE ratio of 9.30 and a beta of 0.71. The stock has a fifty day simple moving average of $4.28 and a 200-day simple moving average of $4.31. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.86 and a quick ratio of 1.26.

Hypermarcas (OTCMKTS:HYPMY) last released its earnings results on Thursday, August 6th. The company reported $0.14 earnings per share for the quarter, topping analysts’ consensus estimates of $0.13 by $0.01. Hypermarcas had a return on equity of 12.68% and a net margin of 19.77%. Equities research analysts anticipate that Hypermarcas will post 0.53 EPS for the current fiscal year.

About Hypermarcas

Hypermarcas SA was a Brazilian consumer health and pharmaceutical company that developed, manufactured and marketed branded products for healthcare, personal care and consumer markets. Its portfolio historically included over-the-counter medicines, prescription products, vitamins, toiletries, cosmetics and other household or personal-care brands.

The company expanded through acquisitions and operated primarily in Brazil, building a broad portfolio of locally recognized brands. In the mid-2010s, Hypermarcas began divesting its non-pharmaceutical businesses to concentrate on healthcare and medicines.